A care home medicines audit is a structured review of whether medicines processes are safe, person-centred, traceable and consistent with the home's policy. It should examine evidence across the full pathway — from admission and ordering to administration, monitoring, incident learning and disposal — rather than checking only whether MAR boxes have been signed.
This practical medicines audit checklist is designed for registered managers, medicines leads, nurses and trained senior staff in adult care homes. It can be used for a full scheduled review, a focused audit after an incident, or a re-audit to confirm that corrective actions have been sustained. It is general guidance, not a substitute for current law, CQC requirements, NICE guidance, local policy or resident-specific clinical advice.
The broad service and commercial owner for care-home support remains Medicina Pharmacy's care home medication management service. This article should own the narrower audit-checklist intent and direct care providers to the service page only when they are ready to discuss pharmacy support.
What a care home medicines audit should achieve
A care home medicines audit should provide assurance, reveal risk and trigger measurable improvement. CQC guidance on good governance explains that providers need effective assurance and auditing systems. A useful audit therefore does more than produce a score: it shows what was examined, what evidence was sampled, what failed, who owns each action and when the service will check again.
The audit should be proportionate. A whole-home review may cover every stage of medicines management, while a focused audit may examine one high-risk area such as missed signatures, refrigerator temperatures, controlled drugs, PRN use or medicines reconciliation after hospital discharge. The scope should be written down before sampling begins.
A care home medicines audit is not a clinical medication review and it does not replace direct observation of staff competency. It also cannot prove that every dose was administered correctly. It combines records, observation, interviews, stock checks and follow-up evidence to build a defensible picture of the system.
Before you start the audit
Before starting the care home medicines audit, set the audit period, resident sample and locations to be reviewed. Include a representative mix of residents and medicine types, such as people using PRN medicines, time-critical medicines, topical preparations, controlled drugs, self-administration arrangements or covert administration plans where these exist.
For the care home medicines audit, gather the current medicines policy, staff role descriptions, competency records, MAR or eMAR reports, care plans, prescription information, delivery records, temperature logs, controlled drug registers, incident reports, disposal records and previous action plans. Confirm which version of each policy or procedure was in force during the audit period.
During the care home medicines audit, use clear ratings such as met, partly met, not met and not applicable. For every exception, record the resident or process affected, the evidence reviewed, the immediate risk, any action already taken and whether clinical escalation was required. Avoid copying identifiable resident information into documents that do not need it.
Care Home Medicines Audit Checklist
Use the following care home medicines audit sequence as a working framework. For each item, record met, partly met, not met or not applicable; cite the evidence; note immediate safeguards; and assign any corrective action. Adapt the sample and detail to the service, resident population, identified risks and local policy.
1. Governance, policy and accountability
Confirm that the medicines policy is current, approved, accessible and specific to the service. It should define responsibilities for ordering, receipt, storage, administration, recording, self-administration, PRN medicines, covert administration, controlled drugs, disposal, incidents, staff training and business continuity. Check that staff can explain their own responsibilities and escalation routes, not simply locate the policy.
2. Admission, transfer and medicines reconciliation
Sample recent admissions, hospital returns and transfers. Check that the resident's current medicines were confirmed from reliable information, discrepancies were resolved, allergies and sensitivities were recorded, and the care plan and MAR or eMAR were updated promptly. Where information conflicted, the record should show who clarified it and what authorised instruction was followed.
3. Ordering, receipt and stock continuity
Review the ordering calendar, responsibilities and recent requests. Compare stock, repeat information, authorised changes and delivery records. Look for over-ordering, omitted items, duplicate supplies, unresolved shortages and medicines carried forward without a documented check. Deliveries should be checked for the correct resident, medicine, strength, form, quantity, directions and condition before items enter active stock.
For a fuller process map, use the ordering medication in care homes guide.
4. MAR or eMAR accuracy and administration records
Check that each medicine record is current, attributable and consistent with the dispensing label and authorised directions. Review missing entries, late entries, unexplained codes, variable-dose records, refused or omitted doses, time-critical medicines and administrations by visiting professionals. CQC guidance requires secure, accurate and up-to-date records; the care home medicines audit should test both completion and the quality of the explanation behind exceptions.
5. PRN, variable-dose and time-specific medicines
For PRN medicines, verify that staff can identify the reason for use, dose range, minimum interval, maximum amount, non-drug measures where relevant, signs that require review and how effectiveness is recorded. For variable doses and time-critical medicines, check that the record gives staff enough unambiguous information to administer safely and escalate when instructions are unclear.
6. High-risk, external and specialist medicines
Sample anticoagulants, insulin, methotrexate, lithium, anti-epileptics, patches, creams, inhalers, eye drops, enteral-tube medicines and any other medicines identified as high risk locally. Confirm that monitoring, application sites, rotation, administration technique, additional charts and specialist instructions are available and current. Do not assume that a MAR signature alone demonstrates correct technique.
7. Controlled drugs
Check secure storage, access controls and the controlled drug register where required. Sample receipt, administration, running balances, transfers and disposal. Entries should be accurate, chronological and traceable, and discrepancies should be escalated promptly under the home's policy. Where a second-person check is used, confirm that it represents a genuine check rather than a retrospective signature.
8. Storage, temperatures and access
Inspect medicine rooms, trolleys, cupboards, refrigerators, emergency supplies and resident-controlled storage. Check security, cleanliness, organisation, expiry dates, separation of medicines awaiting disposal and any additional controls required for refrigerated, external, flammable, self-administered or potentially misused medicines. As part of the care home medicines audit, review temperature records and evidence that out-of-range readings were investigated rather than merely initialled.
9. Consent, capacity, self-administration and covert administration
Check that residents are involved in decisions and supported to self-administer where appropriate. The care plan should describe the level of support, risk assessment, storage arrangements and review. Covert administration requires a person-specific capacity and best-interests process, a clear management plan and review. A general authorisation or a decision covering every medicine without individual consideration is not sufficient.
10. Returns, disposal and end-of-cycle stock
Review how discontinued, expired, damaged and unwanted medicines are identified, recorded, stored securely and transferred for disposal. Check that medicines awaiting disposal are kept separate from active stock and cannot be administered accidentally. Compare disposal records with stock and MAR information where appropriate, especially after death, transfer, dose changes or end-of-cycle returns.
11. Incidents, near misses, safeguarding and learning
Review medicines incidents, near misses, recurring omissions, stock discrepancies and complaints during the audit period. Confirm that the resident was protected, suitable clinical advice was obtained, reporting and notifications were considered, and the investigation looked at system causes such as unclear instructions, workload, interruptions, handovers or training gaps. The action plan should show how learning was shared and whether the change was effective.
Use the medication errors in care homes guide for deeper incident-cause and prevention context.
12. Staff training, competence and supervision
Check that staff who manage or administer medicines have completed relevant training and a formal competency assessment before working independently. CQC guidance recommends annual review of knowledge, skills and competency, with additional training for specialist tasks and after relevant incidents. Audit records should show due dates, observed practice, assessor competence and restrictions where a staff member has not yet met the required standard.
Where training is part of the action plan, review Medicina's medication training for care homes page and confirm the current scope directly with the pharmacy.
13. Medication reviews, monitoring and clinical follow-up
Confirm that residents receive medication reviews and required monitoring according to their needs, current guidance and clinical plans. Check whether falls, swallowing problems, weight change, sedation, pain, behavioural changes, refusal, repeated PRN use or adverse effects have triggered appropriate review. The audit should identify overdue clinical follow-up, but it should not make prescribing decisions.
How to record findings and prioritise action
For each finding, describe the evidence and the resident or system risk. Separate immediate safety actions from longer-term improvement work. A missing time-critical dose, unexplained controlled drug discrepancy or unclear covert-administration decision may require urgent escalation; a formatting inconsistency with no current safety impact may be managed through routine improvement.
The care home medicines audit action plan should assign every action to a named role, set a realistic deadline and define the evidence that will prove completion. Examples include an updated policy, corrected record, staff briefing, competency reassessment, system configuration change, pharmacy query route or repeat sample. "Remind staff" is rarely enough without identifying why the process failed and how compliance will be checked.
Close the loop with a re-audit. The re-audit should test the same risk using fresh evidence and should be scheduled according to severity. Record whether improvement is complete, partly complete, ineffective or not sustained. Unresolved or repeated problems should be escalated through the provider's governance structure.
A practical audit evidence pack
Keep a care home medicines audit cover sheet showing the scope, dates, auditor, sample, criteria and limitations. Retain the completed checklist, anonymised evidence references, immediate actions, the signed action plan, meeting or briefing records and the re-audit result. The evidence pack should make it possible for another competent person to understand how the conclusion was reached.
Where the audit involves digital systems, preserve relevant reports or screenshots in line with data-protection and record-retention requirements. Confirm that exported reports are complete and that staff understand how eMAR alerts, overrides, late entries and audit trails are reviewed. A clean dashboard alone may hide poor-quality explanations or workarounds.
How this checklist fits with related care-home processes
Ordering, medicine receipt and cycle preparation are covered in greater depth in Medicina's ordering guide. The care home medicines audit should sample those processes, while the separate guide remains the owner of the operational ordering intent.
Medication systems for care homes influence what can be audited, but software does not replace governance or competent practice. Likewise, the medication-errors article should remain the specialist page for incident causes and prevention. This checklist uses incidents as audit evidence and focuses on whether actions are completed and sustained.
How pharmacy support can help
A supplying pharmacy can help clarify prescription and delivery discrepancies, agree communication routes, support medicine information queries and contribute to improvement work within the agreed service. Care homes should still retain responsibility for governance, staff competence, care planning, records, incident management and compliance with their own policies and regulatory duties.
Where care home medicines audit findings show repeated ordering issues, unclear communication, training gaps or weaknesses in the wider medicines system, care-home managers can discuss structured pharmacy support. The aim should be a defined improvement plan with clear responsibilities rather than transferring accountability to the pharmacy.
Care Home Medication Management Support
Structured pharmacy support for care homes, including clearer medicines processes, staff training and competency frameworks, and communication around ordering, administration, monitoring and review.
Service scope and availability should be confirmed directly with Medicina Pharmacy. Pharmacy support does not remove the care provider's governance, training, record-keeping or escalation responsibilities.
Conclusion
A care home medicines audit works best when it connects evidence to action. Review the complete pathway, sample high-risk situations, speak with staff, compare records with stock and practice, and document both immediate safety responses and longer-term improvements.
Use the findings to strengthen policy, training, communication and resident-specific care. Then re-audit the highest risks to confirm that change has been sustained. A well-run care home medicines audit supports good governance and safer practice, but it must remain part of an ongoing system rather than a one-off inspection exercise.
FAQs
What is a care home medicines audit?
A care home medicines audit is a structured check of how medicines are governed, ordered, received, stored, administered, recorded, reviewed and disposed of. It compares current practice and evidence with the home's policy, current guidance and agreed procedures, then records findings and improvement actions.
How often should a care home medicines audit be completed?
There is no single universal frequency for every audit area. The home's medicines policy should define a risk-based schedule. Full audits, focused spot checks and re-audits may be needed after incidents, recurring omissions, staff changes, system changes, admissions or transfers.
Who should lead a care home medication audit?
A competent person with sufficient authority and medicines knowledge should lead the audit. Depending on the scope, this may be a registered manager, medicines lead, nurse, senior care worker, governance lead or another suitably trained person, with specialist advice where needed.
What should be checked on MAR or eMAR records?
Check that records are current, legible or clearly attributable, linked to the correct resident and medicine, and completed at the time support is provided. Review omissions, codes, variable doses, time-critical medicines, PRN outcomes, external administration and changes after hospital or prescriber updates.
How should PRN medicines be audited?
Check that each PRN medicine has clear person-centred instructions covering the reason for use, dose, minimum interval, maximum amount, non-drug measures where relevant and when to seek advice. Records should show why it was given, the dose and time, and whether it worked.
What should happen when an audit finds a medicines problem?
Protect the resident first, obtain clinical advice when required, record and report the issue under the home's policy, investigate the system causes and assign a corrective action with an owner and deadline. Re-audit to confirm that the action is working and has been sustained.
Is a medicines audit the same as a medication review?
No. A medicines audit checks systems, records and practice across the care service. A medication review is a clinical review of an individual resident's medicines, outcomes, risks and preferences by an appropriate healthcare professional. The two processes should inform each other but are not interchangeable.
Does completing this checklist guarantee CQC compliance?
No. A checklist can support governance and improvement, but it cannot guarantee compliance, inspection outcomes or resident safety. Providers must apply current law, CQC requirements, NICE guidance, local policy, professional advice and person-specific care planning.
